Preprint
Prevalence of anti-SARS-CoV-2 immunity in Kazakhstan before the launch of COVID-19 vaccination
Abstract
Abstract Background COVID-19 exposure in Central Asia appears underestimated and SARS-CoV-2 seroprevalence data are urgently needed to inform ongoing vaccination efforts and other strategies to mitigate the regional pandemic. Here, we assessed the prevalence of anti-SARS-CoV-2 antibody-mediated immunity in a heterogeneous cohort of public university employees in Karaganda, Kazakhstan. Methods Asymptomatic subjects (n=100) were recruited …
Authors
Kadyrova I; Yegorov S; Negmetzhanov B; Kolesnikova Y; Kolesnichenko S; Korshukov I; Vazenmiller D; Stupina Y; Kabildina N; Ashimova A
DOI
10.1101/2021.09.03.21262885
Preprint server
medRxiv